AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-muscle and Muscle Invasive) - Joshua Meeks and Sima Porten #BladderCancer #UroToday urotoday.com/video-lectures…

FDA approves Pfizer/Merck KGaA’s Bavencio in first line bladder cancer #BladderCancer ow.ly/Yjdi50AmSqg

The RESECT Study: Improving Quality in TURBT Surgery - Veeru Kasivisvanathan #BladderCancer #UroToday urotoday.com/video-lectures…

FDA Approves Avelumab as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carcinoma #BladderCancer #UroToday ow.ly/ZZLC50Ao0KW

The emerging role of antibody-drug conjugates in urothelial carcinoma. #BladderCancer #UroToday ow.ly/5jFo50AqAFO

Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma. #BladderCancer #UroToday ow.ly/4Yp250AqAHG

Urobiome in Gender-Related Diversities of Bladder Cancer. #BladderCancer #UroToday urotoday.com/recent-abstrac…

Biopsy at flexible cystoscopy: is it worthwhile? #UroToday #BladderCancer ow.ly/Sg6R50AwK1s

Can we treat bladder cancer with intravesical Bacillus Calmette-Guerin in patients with prior tuberculosis infection? A population-based cohort study. #UroToday #BladderCancer ow.ly/7wqt50AwK3m

The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort. #BladderCancer #UroToday ow.ly/4Wvu50AyWc8

Bladder cancer incidence rates and trends in young adults aged 20-39 years. #BladderCancer #UroToday ow.ly/koDA50AyWfQ

Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer. #BladderCancer #UroToday ow.ly/lWtv50ADeGx

EAU 2020: Five Things I Wish I Would Have Known Earlier in My Career: Lessons from the Mentors - Bladder Cancer #BladderCancer #UroToday ow.ly/mI4n50ADeKr

UGN-101 (mitomycin gel): a novel treatment for low-grade upper tract urothelial carcinoma. #BladderCancer #UroToday ow.ly/7K7C50ADeIw

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer. #BladderCancer #UroToday ow.ly/vcZz50AFe0T

Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer. #BladderCancer #UroToday ow.ly/UuKu50AGc2i

TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer. #BladderCancer #UroToday ow.ly/vGEf50AGc4f

Bladder Cancer in Times of COVID-19 in India - Pradeep P. Rao #BladderCancer #UroToday ow.ly/v5Pe50AHc8f

Upregulation of lncRNA plasmacytoma variant translocation 1 predicts poor prognosis in patients with muscle-invasive bladder cancer. #BladderCancer #UroToday ow.ly/ypNi50AHcaK

Cytotoxic CD4+ T Cells in Bladder Cancer-A New License to Kill. #BladderCancer #UroToday ow.ly/lm0l50AHcd6